Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human GALR1 Stable Cell Line

    [CAT#: S01YF-0923-PY71]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    GPCR Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Product Information

    Target Protein
    GALR1
    Target Family
    Galanin Family
    Target Protein Species
    Human
    Host Cell Type
    LX-2;CHO-K1;HEK293
    Target Classification
    GPCR Cell Lines
    Target Research Area
    CNS Research
    Related Diseases
    Chromosome 18Q Deletion Syndrome;Auditory Agnosia
    Gene ID
    Human: 2587
    UniProt ID
    Human: P47211

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    GALR1 is a receptor for the neuropeptide galanin. Recent studies have highlighted its expression in colorectal cancer tissues and its potential correlation with overall survival and prognosis in colorectal cancer patients. Additionally, GALR1 has been associated with epigenetic alterations in colorectal carcinogenesis, suggesting its role in neoplastic progression. In the context of opioid withdrawal, GALR1's expression in the locus coeruleus has been studied, emphasizing its potential role in opioid responses.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human GALR1 Stable Cell Line (S01YF-0923-PY71). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Amy (Verified Customer)

    How does GALR1 immunoexpression correlate with the overall survival of colorectal cancer patients? Aug 29 2020

    chat Patrick Liam (Creative Biolabs Scientific Support)

    High expression of GALR1 in the submucosal plexuses has been correlated with the overall survival of colorectal cancer patients, suggesting that GAL and GALRs might play a role in local neuro-paracrine pro-proliferative pathways accelerating the invasion and metastasis of cancer cells. Aug 29 2020

    chat Sharon (Verified Customer)

    Is there an epigenetic alteration in the GALR1 promoter during colorectal neoplastic progression? Nov 02 2021

    chat Patrick Liam (Creative Biolabs Scientific Support)

    Yes, epigenetic alteration of the GALR1 promoter has been observed to accumulate gradually during colorectal neoplastic progression, indicating its potential as a promising biomarker for screening and surveillance of colorectal cancer. Nov 02 2021

    Published Data

    Fig.1 GalR1 plays a pivotal role in orchestrating cholangiocyte-driven LX-2 cell activation via intricate autocrine and paracrine mechanisms.

    Alterations in mRNA expression of α-smooth muscle actin (α-SMA) and Col1A1 within LX-2 cells were observed upon exposure to conditioned media sourced from non-transfected cholangiocytes (Ch-med), cholangiocytes transfected with siRNA_scr (Ch+scr), cholangiocytes transfected with siRNA_1 (Ch+si1), or siRNA_2 (Ch+si2), alongside vehicle, Gal, M617, or AR-M. A total of four replicates were analyzed, with statistically significant differences denoted as *P < 0.05 for Gal/M617/AR-M compared to the vehicle group.

    Ref: Petrescu, Anca D., et al. "Coordinated targeting of galanin receptors on cholangiocytes and hepatic stellate cells ameliorates liver fibrosis in multidrug resistance protein 2 knockout mice." The American Journal of Pathology 190.3 (2020): 586-601.

    Pubmed: 31953035

    DOI: 10.1016/j.ajpath.2019.10.023

    Research Highlights

    Gallagher DM, et al. "An update on galanin and spexin and their potential for the treatment of type 2 ." Peptides, 2023.
    Spexin (SPX) and galanin (GAL) are two neuropeptides with widespread distribution in the central nervous system and peripheral tissues in various species including humans. Their biological effects are mediated by interactions with galanin receptors (GALR), namely GALR1, GALR2, and GALR3. While GAL can bind to all three receptors, SPX has a more specific affinity for GALR2 and GALR3. While the roles of GAL are well-documented, the physiological actions of SPX are still being studied. Both peptides are involved in regulating energy homeostasis and have potential therapeutic applications in obesity and type 2 diabetes mellitus. GAL may be more effective for treating eating disorders, while SPX may be useful for obesity and related forms of diabetes. This narrative review provides updated information on the biology of SPX and GAL and potential therapeutic uses for metabolic disorders.
    Pubmed: 37714335   DOI: 10.1016/j.peptides.2023.171096

    Caramia M, et al. "Neuronal diversity of neuropeptide signaling, including galanin, in the mouse ." Proceedings of the National Academy of Sciences of the United States of America, 2023.
    The locus coeruleus (LC) is a small pons nucleus that innervates major parts of the central nervous system through ascending and descending projections. Norepinephrine (NE) is the main neurotransmitter released by this system, which is evolutionarily conserved and known to be involved in regulating wakefulness and linked to disorders like depression. Using single-cell RNA sequencing, researchers have identified 24 distinct clusters of neurons in the LC, including 3 NE, 17 glutamate, and 5 gamma-aminobutyric acid (GABA) subtypes. They have also discovered that NE neurons express multiple neuropeptides and receptors, particularly galanin (Gal) and Galr1, which have been shown to inhibit NE activity through direct interaction. This suggests a potential role for the galanin system in modulating NE functions and provides a basis for studying other neuropeptides and their receptors.
    Pubmed: 37487094   DOI: 10.1073/pnas.2222095120

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare